NCT07198386View on ClinicalTrials.gov

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 5, 2026

Study Completion Date

May 6, 2026

Conditions
NASH
Interventions
DRUG

CS060380

Oral QD

DRUG

Placebo

Oral QD

Trial Locations (1)

311121

RECRUITING

The Affiliated Hospital of Hangzhou Normal University, Hangzhou

Sponsors
All Listed Sponsors
lead

Cascade Pharmaceuticals, Inc

OTHER

NCT07198386 - Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter